Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cureus|January 19, 2019
Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the LiteratureJennifer A Lewis, William J Petty, James Urbanic, et al.
The Clinical Teacher|December 4, 2018
An evidence-based medicine approach for case presentations by traineesThomas W Lycan, Tamjeed Ahmed, Mary Beth Seegars, et al.
Journal of Neurology|May 16, 2018
Severe neurologic complications of immune checkpoint inhibitors: a single-center reviewSarah Mancone, Thomas Lycan, Tamjeed Ahmed, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|July 2, 2019
Lost in Translation: Diagnosis Records Show More Inaccuracies After Biopsy in Oncology Care EHRsJose-Franck Diaz-Garelli, Roy Strowd, Brian J Wells, et al.
Cancers of the Head & Neck|May 17, 2019
Human papillomavirus-related small cell carcinoma of the oropharynx: a case report and literature reviewMarcelo Bonomi, Tamjeed Ahmed, David Warner, et al.
JCO Clinical Cancer Informatics|May 14, 2021
What Oncologists Want: Identifying Challenges and Preferences on Diagnosis Data Entry to Reduce EHR-Induced Burden and Improve Clinical Data QualityFranck Diaz-Garelli, Roy Strowd, Tamjeed Ahmed, et al.
JAMIA Open|January 28, 2020
A tale of three subspecialties: Diagnosis recording patterns are internally consistent but Specialty-DependentJose-Franck Diaz-Garelli, Roy Strowd, Tamjeed Ahmed, et al.
The American Journal of Hospice & Palliative Care|May 5, 2022
Team-Based Hospice Referrals: A Potential Quality Metric for Lung Cancer in the Immunotherapy EraThomas W Lycan, Alyssa Buckenheimer, Jimmy Ruiz, et al.
Oncology Letters|January 19, 2019
Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysisMarcelo Bonomi, Tamjeed Ahmed, Safoa Addo, et al.
Clinical Lung Cancer|February 25, 2020
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non-Small-Cell Lung CancerTamjeed Ahmed, Thomas Lycan, Andy Dothard, et al.
Pageof 3